These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9412546

  • 1. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant.
    Collet JP, Shapiro P, Ernst P, Renzi T, Ducruet T, Robinson A.
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1719-24. PubMed ID: 9412546
    [Abstract] [Full Text] [Related]

  • 2. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
    Jara-Pérez JV, Berber A.
    Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
    [Abstract] [Full Text] [Related]

  • 3. Economic impact of using an immunostimulating agent to prevent severe acute exacerbations in patients with chronic obstructive pulmonary disease.
    Collet JP, Ducruet T, Haider S, Shapiro S, Robinson A, Renzi PM, Contandriopoulos AP, Ernst P.
    Can Respir J; 2001 Jun; 8(1):27-33. PubMed ID: 11223497
    [Abstract] [Full Text] [Related]

  • 4. [Preventive effect of an immunomodulator, OM-85 BV, on acute exacerbations of chronic bronchitis in elderly patients. Preliminary results at six months in 291 patients].
    Orcel B, Delclaux B, Baud M, Derenne JP.
    Rev Mal Respir; 1993 Jun; 10(1):23-8. PubMed ID: 8451491
    [Abstract] [Full Text] [Related]

  • 5. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.
    Razi CH, Harmancı K, Abacı A, Özdemir O, Hızlı S, Renda R, Keskin F.
    J Allergy Clin Immunol; 2010 Oct; 126(4):763-9. PubMed ID: 20920766
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease.
    Li J, Zheng JP, Yuan JP, Zeng GQ, Zhong NS, Lin CY.
    Chin Med J (Engl); 2004 Jun; 117(6):828-34. PubMed ID: 15198881
    [Abstract] [Full Text] [Related]

  • 7. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D, Varricchio A, D'Ambrosio S, Ascione E, Motta G.
    Arzneimittelforschung; 2004 Jun; 54(1):57-63. PubMed ID: 14979610
    [Abstract] [Full Text] [Related]

  • 8. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
    Solèr M, Mütterlein R, Cozma G, Swiss-German OM-85 Study Group.
    Respiration; 2007 Jun; 74(1):26-32. PubMed ID: 16772707
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months.
    Gutiérrez-Tarango MD, Berber A.
    Chest; 2001 Jun; 119(6):1742-8. PubMed ID: 11399700
    [Abstract] [Full Text] [Related]

  • 10. [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children].
    Gómez Barreto D, De la Torre C, Alvarez A, Faure A, Berber A.
    Allergol Immunopathol (Madr); 1998 Jun; 26(1):17-22. PubMed ID: 9585823
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease.
    Tang H, Fang Z, Saborío GP, Xiu Q.
    Lung; 2015 Aug; 193(4):513-9. PubMed ID: 26044556
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection].
    Liao JY, Zhang T.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):508-12. PubMed ID: 24857002
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study.
    Souza FC, Mocellin M, Ongaratto R, Leitão LAA, Friedrich FO, Silveira VD, Scotta MC, Pitrez PM, Pinto LA.
    Einstein (Sao Paulo); 2020 May; 18():eAO5262. PubMed ID: 32130328
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review.
    Sprenkle MD, Niewoehner DE, MacDonald R, Rutks I, Wilt TJ.
    COPD; 2005 Mar; 2(1):167-75. PubMed ID: 17136978
    [Abstract] [Full Text] [Related]

  • 18. [Effect of Broncho-Vaxom on serum IgE and IgG levels in patients with bronchial asthma and chronic obstructive lung disease. A placebo-controlled double-blind study].
    Weiss S, Fux T.
    Schweiz Med Wochenschr; 1987 Sep 26; 117(39):1514-8. PubMed ID: 3672087
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of the immunostimulant Broncho-Vaxom].
    Ahrens J, Wiedenbach M.
    Schweiz Med Wochenschr; 1984 Jun 23; 114(25):932-4. PubMed ID: 6379870
    [Abstract] [Full Text] [Related]

  • 20. Effects of OM-85 BV in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Pan L, Jiang XG, Guo J, Tian Y, Liu CT.
    J Clin Pharmacol; 2015 Oct 23; 55(10):1086-92. PubMed ID: 25903441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.